,SETD8

He Chen1, Rudra Prasad Dutta2, Zhizhong Li3

  • 1Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.

PubMed
概括

一种新的共价抑制剂,MS2928,有效地准多发性骨髓瘤细胞中的SET域含有蛋白8 (SETD8). 这种强大的化合物在临床前模型中减少了瘤的生长,为表观遗传疗法提供了一个有前途的途径.